Interesting in the reply from David Cade, that insufficeint...

Interesting in the reply from David Cade, that insufficeint 'events' (deaths) have occured, and thus the small delay. Good for the 460 pts on trial.

Despit what GW said about drawing no interpretation,

One has to assume that this in on both arms, as if only on one arm then the result would be a tad more cut and dry?

Thoughts?

Q was from David Stanton CMSA(?)

---------

John Hester, Bell Potter, also asked a Q about the planning for various oucomes of the trials.
David Cade referred to HCC and only 1 new treatment in the last 10 years, and being a very difficult case to treat. he did make the point as has been discussed on this forum, that even if there is no significant improvement in OS, that is the OS is about the same then the clinical outcome could be very posative due to the intolerance of many pts to Nexavar.